Has Richard Texada, MD received payments from drug or device companies?

Yes. Drug and device makers reported $201 in general payments to Richard Texada, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Texada, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Texada, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Texada, MD

Orthopaedic Surgery · Slidell, LANPI 1790751030

Payments from drug & device makers

$201in general payments, 2019–2025

Across 13 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arbor Pharmaceuticals, Inc.$46
Pacira Therapeutics, Inc.$42
Saluda Medical Americas, Inc.$20
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$20
Stryker$18
Pacira Pharmaceuticals Incorporated$16
plus $39 from 3 others

What the payments were for

Food & beverage$201100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arbor Pharmaceuticals, Inc.	3	$46
Pacira Therapeutics, Inc.	3	$42
Saluda Medical Americas, Inc.	1	$20
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$20
Stryker	1	$18
Pacira Pharmaceuticals Incorporated	1	$16
Medtronic	1	$15
Sentynl Therapeutics, Inc.	1	$12
Amgen	1	$12

How this compares

$201 in reported general payments places this provider in the 10th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024

$137,114

Medicare patients

210

Services billed

10,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	17	$4,535
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	78	$893
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	58	$444
Meloxicam	71	$241
Gabapentin	19	$126
Tramadol Hcl	21	$81

Paid to pharmacies, not to this prescriber.

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other orthopaedic surgery in Slidell